These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9412364)

  • 1. [Medical treatment of bladder instability. Our experience].
    Zubiaur Líbano C; Loizaga Iriarte A; Ullate Jaime V; García Sastre E; Arciniega García JM; Infante Riaño R; Flores Corral N
    Arch Esp Urol; 1997; 50(6):633-42. PubMed ID: 9412364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In which patients is the oxybutynin-desmopressin combination therapy indicated?].
    Martín-Crespo R; Luque R
    Cir Pediatr; 2003 Oct; 16(4):181-5. PubMed ID: 14677356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
    Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
    Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of driptan (oxybutinin) in patients with urgent forms of urination disorders].
    Loran OB; Pushkar' DIu; Tevlin KP
    Urol Nefrol (Mosk); 1998; (6):24-6. PubMed ID: 10051823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of effectiveness of and tolerance to oxybutynin in the treatment of unstable bladder in women].
    Serrano Brambila EA; Quiroga Avila RG; Lorenzo Monterrubio JL; Moreno Aranda J
    Ginecol Obstet Mex; 2000 Apr; 68():174-81. PubMed ID: 10824450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of oral anticholinergic therapy in children under 1 years of age with high risk bladder].
    Luque Mialdea R; Martín-Crespo R; Hernández E; Sánchez O; Cañizo A; Fernández A; Aparicio C; Blanco T; Cebrían J
    Cir Pediatr; 2005 Jan; 18(1):3-7. PubMed ID: 15901100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effects of intrarectal administration of oxybutynin].
    Radziszewski P; Borkowski A
    Wiad Lek; 2002; 55(11-12):691-8. PubMed ID: 12715351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, tolerability and safety of propiverine hydrochloride in children and adolescents with congenital or traumatic neurogenic detrusor overactivity--a retrospective study.
    Grigoleit U; Mürtz G; Laschke S; Schuldt M; Goepel M; Kramer G; Stöhrer M
    Eur Urol; 2006 Jun; 49(6):1114-20; discussion 1120-1. PubMed ID: 16542772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
    Bach P; Wormland RT; Möhring C; Goepel M
    Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined treatment of patients with detrusor instability].
    Al-Shukri SKh; Kuz'min IV; Amdiĭ RE
    Urologiia; 2001; (5):26-9. PubMed ID: 11641975
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of terodiline on patients with detrusor instability.
    Macfarlane JR; Tolley DA
    Scand J Urol Nephrol Suppl; 1984; 87():51-4. PubMed ID: 6399954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incontinence in the older woman.
    Walsh A
    Ir Med J; 1995; 88(5):151. PubMed ID: 8575899
    [No Abstract]   [Full Text] [Related]  

  • 15. Is extended-release oxybutynin (Ditropan XL) or tolterodine (Detrol) more effective in the treatment of an overactive bladder?
    Hartnett NM; Saver BG
    J Fam Pract; 2001 Jul; 50(7):571. PubMed ID: 11485700
    [No Abstract]   [Full Text] [Related]  

  • 16. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.
    Stöhrer M; Mürtz G; Kramer G; Schnabel F; Arnold EP; Wyndaele JJ;
    Eur Urol; 2007 Jan; 51(1):235-42. PubMed ID: 16698176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oxybutinin-desmopressin association in the treatment of primary nocturnal enuresis with diurnal urination disorders].
    De Grazia E; Cimador M
    Minerva Pediatr; 1999 May; 51(5):149-52. PubMed ID: 10479880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesically administered ketoprofen in treatment of detrusor instability: cross-over study.
    Sprem M; Milicić D; Oresković S; Ljubojević N; Kalafatić D
    Croat Med J; 2000 Dec; 41(4):423-7. PubMed ID: 11063767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enuresis.
    Cossio SE
    South Med J; 2002 Feb; 95(2):183-7. PubMed ID: 11846242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.